Alliance for Regenerative Medicine

Advocacy organization supporting advances in regenerative medicine.

Based in DC

🤖

AI Overview

With $1.6M in lobbying spend across 29 quarterly filings, Alliance for Regenerative Medicine is a significant lobbying presence. Their lobbying covers 2 issue areas. Active from 2018 to 2024.

$1.6M
Total Spend
7
Years Active
1
Firms Hired
7
Lobbyists Deployed
2
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2018$250K
2019$200K
2020$200K
2021$200K
2022$280K
2023$360K
2024$120K

Issues Lobbied

Lobbying Firms

Lobbyists

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid

  • Implementation of 21st Century Cures regenerative medicine provisions; H.R. 2430, S. 204, Trickett Wendler Right to Try Act; other FDA-related issues.
  • Implementation of 21st Century Cures regenerative medicine provisions; H.R. 2430, S. 204, Trickett Wendler Right to Try Act; other FDA and CMS-related issues.
  • Implementation of 21st Century Cures regenerative medicine provisions; regulatory and reimbursement issues.

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.